North American Cannabis Holdings Anticipates Explosive Growth in $140 Billion Market

DALLAS, September 4, 2018 /PRNewswire/ --

North American Cannabis Holdings (USOTC: USMJ) a cannabis industry leader and innovator since 2013, today previewed an up and coming launch anticipated to realize explosive growth over the next 24 months. Over the last few months the company has published information on substantial steps that are all part of a plan to seize market share within the legal global cannabis market predicted to reach $140 billion dollars by 2027 according analysis by European investment bank Bryan, Garnier & Co. The strategy includes a spinoff of North American Cannabis Holdings' AmeriCanna Cafe subsidiary to include a dividend distribution of spinoff shares to shareholders. North American Cannabis Holdings will maintain a wholesale distribution business to the restaurant spinoff.  The spinoff operation plans to expand the AmeriCanna Cafe business and diversify into additional restaurant operations. The spinoff restaurant business will exclusively utilize North American Cannabis Holdings wholesale distribution operations.  North American Cannabis Holdings also intends to launch a retail business selling direct to consumers through an online portal.  The Company expects to launch a new website later this week revealing specific details on this strategy with specific details on the anticipated growth. Look for the new website at http://www.growusmj.com.

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Steven Rash
CEO North American Cannabis Holdings, Inc.
[email protected]
+1-800-861-1350

SOURCE North American Cannabis Holdings, Inc.